Articles

Fed’s Barkin thinks the U.S. economy will slow further, cooling down inflation

Recent data whiplash only confirms the wisdom of being slow to move interest rates, the Richmond Fed president says.

Biden to tout Microsoft expansion at site where Trump-backed Foxconn plant flopped: report

President Joe Biden’s visit to Wisconsin on Wednesday will feature the Democratic incumbent highlighting a Microsoft expansion plan on land meant for Foxconn during the Trump era, according to a Milwaukee newspaper’s report.

College commencement season in America disrupted as Columbia cancels main ceremony

Some colleges have canceled their school-wide ceremonies, while other schools are planning for disruption.

Trump’s Truth Social dismisses accounting firm after SEC accused it of ‘massive fraud’

BF Borgers agreed to pay a $14 million fine after admitting it had falsely claimed filings for hundreds of companies met accounting standards.

History shows quiet weeks for economic data are often the best weeks for stocks. Here’s what to watch.

U.S. stocks were rising on Monday, kicking off what promises to be a relatively quiet week for economic data. History says weeks with a quiet macroeconomic calendar have seen better-than-average returns for the stock market, according to BofA Global Research.

GameStop’s stock slides 12% after skyrocketing last week

The videogame retailer and original meme stock ended Friday’s session up 29.1%.

Citi sees ‘coiled spring’ for bank stocks, with Hancock Whitney in the spotlight

Citi analyst Ben Gerlinger sees bank stock as “attractive” for significant gains over the summer.

Americans expect mortgage rates to rise to nearly 10% in the next three years, New York Fed housing survey finds

U.S. consumers expect mortgage rates to rise to near double digits over the next three years, according to a new survey by the New York Federal Reserve.

Robinhood’s stock dives after receipt of SEC ‘Wells Notice’ disclosed

The company said the “Wells Notice” states that the SEC Staff decided to recommend the SEC file “an enforcement action” against Robinhood, alleging securities violations.

EyePoint Pharmaceuticals’ stock plunges as eye treatment fails to meet trial goal

Shares of EyePoint Pharmaceuticals dropped nearly 30% premarket on Monday after the company said its experimental eye disease treatment failed to meet a clinical trial’s main goal.

Trump’s war against short-sellers appears to be paying dividends as DJT’s stock rises

Ever since the former president’s media company began blaming Truth Social’s stock woes on naked short selling, its share price has more than doubled.

Clean-energy producer Allete agrees to go private for $6.2 billion

Canada Pension Plan Investment Board and Global Infrastructure Partners team up to pay $67 a share.
1 1,384 1,385 1,386 1,387 1,388 2,504